Newsroom
Sorted by: Latest
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Buffer UCITS ETF - July 23.09.2026 FJUL.LN IE000YJBT6I5 100,002.00 USD 2,940,733.99 29.407 ...
-
Le podcast Doha Debates revient pour une nouvelle saison consacrée aux idées qui façonnent notre monde
DOHA, Qatar--(BUSINESS WIRE)--Doha Debates, une initiative de Qatar Foundation, a lancé une nouvelle saison du Doha Debates Podcast, composée de 20 épisodes diffusés chaque semaine jusqu’au 16 février 2027. La série réunit d’éminents penseurs du monde entier pour débattre de certaines des questions les plus complexes et les plus difficiles auxquelles le monde est confronté. Le podcast prolonge les thèmes abordés dans ses débats phares et ses assemblées publiques à travers des conversations appr...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Buffer UCITS ETF - October 23.09.2026 FOCT.LN IE0004X8KUG5 100,002.00 USD 3,014,126.09 30.141 ...
-
SLB Awarded Four Multi-Year Integrated Well Construction Contracts by Aramco
HOUSTON--(BUSINESS WIRE)--Global energy technology company SLB (NYSE: SLB) today announced it has been awarded four integrated well construction contracts by Aramco to support oil and gas development across the Kingdom of Saudi Arabia. Under the contracts, SLB will manage end-to-end well construction services, delivering more than 450 wells in the three-year term, with an optional extension of up to two years. "Delivering hundreds of wells across a multi-year program and in multiple operating e...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Buffer UCITS ETF 10% - January 23.09.2026 FJAN.LN IE000MDKBOB3 150,002.00 USD 4,441,580.53 29.610 ...
-
Sahajanand Medical Technologies Receives EU MDR Certification for Supraflex Cruz and Product Family, Reinforcing Global Compliance and Patient Safety
MUMBAI, India--(BUSINESS WIRE)--Sahajanand Medical Technologies today announced that it has received certification under the EU MDR for Supraflex Cruz and its product family....
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Nasdaq Clean Edge Global Water UCITS ETF 23.09.2026 H2O LN IE000Q8F0M81 600,002.00 USD 11,806,655.42 19.678 ...
-
Frost Radar™ Recognizes XiFin as the Only AI-enabled Ancillary Healthcare RCM Specialist Among Leading North American Providers
SAN DIEGO--(BUSINESS WIRE)--XiFin, Inc., a leader in AI-enabled revenue cycle management (RCM), today announced it has been recognized in the Frost Radar™: Revenue Cycle Management Operations in North America. Frost & Sullivan evaluated more than 100 companies and identified XiFin as one of only 15 providers recognized on its Growth and Innovation indices, and the only company focused exclusively on ancillary healthcare revenue cycle management. Frost & Sullivan estimates the North Amer...
-
Skylark Bio Expands Pipeline with First CNS Development Program, SKY-AS, Targeting UBE3A Restoration in Angelman Syndrome
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Skylark Bio, a clinical-stage biotechnology company developing precision genetic medicines for monogenic disorders, is expanding its pipeline with SKY-AS, a differentiated gene therapy candidate designed to restore UBE3A expression in individuals with Angelman syndrome (AS). SKY-AS represents the company's first central nervous system (CNS) development program and expands Skylark's growing portfolio of precision, locally delivered genetic medicines. AS is a ra...
-
Basalt Health Raises $20M Series A Led by NEA to Speed Post-Acute Admissions
NASHVILLE, Tenn.--(BUSINESS WIRE)--Basalt Health, the AI platform that helps patients transition to post-acute care faster, today announced a $20 million Series A financing led by return investor NEA, with participation from existing investors Frist Cressey Ventures and 25m Health. The round brings the company’s total capital raised to approximately $24.5 million. Each year, roughly 14 million patients enter post-acute care—yet the placement process has failed to evolve. The archaic process typ...